In last trading session, Rockwell Medical Inc (NASDAQ:RMTI) saw 0.31 million shares changing hands with its beta currently measuring 1.64. Company’s recent per share price level of $1.00 trading at -$0.02 or -1.96% at ring of the bell on the day assigns it a market valuation of $34.06M. That closing price of RMTI’s stock is at a discount of -415.0% from its 52-week high price of $5.15 and is indicating a discount of -1.0% from its 52-week low price of $1.01. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.32 million shares which gives us an average trading volume of 272.06K if we extend that period to 3-months.
For Rockwell Medical Inc (RMTI), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0 in the current quarter.
Rockwell Medical Inc (NASDAQ:RMTI) trade information
Upright in the red during last session for losing -1.96%, in the last five days RMTI remained trading in the red while hitting it’s week-highest on Monday, 03/31/25 when the stock touched $1.00 price level, adding 12.28% to its value on the day. Rockwell Medical Inc’s shares saw a change of -50.98% in year-to-date performance and have moved -12.28% in past 5-day. Rockwell Medical Inc (NASDAQ:RMTI) showed a performance of -37.50% in past 30-days. Number of shares sold short was 0.52 million shares which calculate 2.72 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 3 to the stock, which implies a rise of 66.67% to its current value. Analysts have been projecting 3 as a low price target for the stock while placing it at a high target of 3. It follows that stock’s current price would drop -200.0% in reaching the projected high whereas dropping to the targeted low would mean a loss of -200.0% for stock’s current value.
Rockwell Medical Inc (RMTI) estimates and forecasts
This year revenue growth is estimated to fall -33.57% from the last financial year’s standing.
2 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 17.46M for the same. And 2 analysts are in estimates of company making revenue of 16.77M in the next quarter. Company posted 22.68M and 25.83M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 66.71% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -477.78% while estimates for its earnings growth in next 5 years are of -18.56%.
Rockwell Medical Inc (NASDAQ:RMTI)’s Major holders
Insiders are in possession of 12.11% of company’s total shares while institution are holding 24.33 percent of that, with stock having share float percentage of 27.69%. Investors also watch the number of corporate investors in a company very closely, which is 24.33% institutions for Rockwell Medical Inc that are currently holding shares of the company. ARMISTICE CAPITAL, LLC is the top institutional holder at RMTI for having 3.22 million shares of worth $5.67 million. And as of 2024-06-30, it was holding 10.5795 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 1.12 million shares on 2024-06-30. The number of shares represents firm’s hold over 3.8131 of outstanding shares, having a total worth of $1.97 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 811.89 shares of worth $0.81 million or 2.38% of the total outstanding shares. The later fund manager was in possession of 355.64 shares on Dec 31, 2024 , making its stake of worth around $0.36 million in the company or a holder of 1.04% of company’s stock.
